Literature DB >> 4389283

Blockade or reversal of the contraction induced by calcium and adrenaline in depolarized arterial smooth muscle.

T Godfraind, A Kaba.   

Abstract

1. Mesenteric arteries immersed in a depolarizing solution contract in the presence of calcium. These contractions are proportional to the calcium concentration and are reversible.2. Mesenteric arteries immersed in a calcium-free depolarizing solution contract in the presence of adrenaline. Under the experimental conditions reported here, this response develops only about one-third of the contractile tension developed in polarizing solution (modified Krebs bicarbonate).3. Cinnarizine and chlorpromazine inhibit the contractile response to calcium and induce relaxation of depolarized muscle previously contracted by calcium; cinnarizine was 4 times more potent than chlorpromazine in such activity.4. Chlorpromazine inhibits the response to adrenaline in both polarizing and calcium-free depolarizing solutions, whereas cinnarizine inhibits the response in polarizing solution but not that in calcium-free depolarizing solution.5. The significance of these results is discussed.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4389283      PMCID: PMC1703600          DOI: 10.1111/j.1476-5381.1969.tb08010.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  The inhibition of the sarcoplasmic calcium pump produced by agents which react with its lipid component: reserpine, prenylamine, chlorpromazine, imipramine.

Authors:  H Balzer; M Makinose
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

2.  Antagonizing action of chlorpromazine, dibenamine, and phenoxybenzamine on potassium-induced contraction.

Authors:  S Shibata; O Carrier
Journal:  Can J Physiol Pharmacol       Date:  1967-07       Impact factor: 2.273

3.  The action of isoprenaline in the depolarized rat uterus.

Authors:  H O Schild
Journal:  Br J Pharmacol Chemother       Date:  1967-11

4.  Differences in sensitivity of arterial smooth muscles to inhibition of their contractile response to depolarization by potassium.

Authors:  T Godfraind; A Kaba; P Polster
Journal:  Arch Int Pharmacodyn Ther       Date:  1968-03

5.  Studies on the radiocalcium uptake and the adenosine triphosphatases of skeletal and cardiac sarcoplasmic reticulum fractions (SRF).

Authors:  B Scales; D A McIntosh
Journal:  J Pharmacol Exp Ther       Date:  1968-04       Impact factor: 4.030

6.  Electromechanical and pharmacomechanical coupling in vascular smooth muscle.

Authors:  A V Somlyo; A P Somlyo
Journal:  J Pharmacol Exp Ther       Date:  1968-01       Impact factor: 4.030

7.  Effects of manganese on the response of aortic strips to angiotensin and norepinephrine contractions.

Authors:  L J Sullivan; A H Briggs
Journal:  J Pharmacol Exp Ther       Date:  1968-06       Impact factor: 4.030

8.  Differential effects of calcium removal upon vascular smooth muscle contraction induced by norepinephrine, histamine and potassium.

Authors:  P M Hudgins; G B Weiss
Journal:  J Pharmacol Exp Ther       Date:  1968-01       Impact factor: 4.030

9.  Adrenergic receptors in coronary arteries.

Authors:  D F Bohr
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

10.  Calcium and the relaxant effect of isoproterenol in the depolarized rat uterus.

Authors:  H O Schild
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

View more
  46 in total

1.  Force velocity relations in vascular smooth muscle: the influence of pH, pCa, and noradrenaline.

Authors:  U Peiper; M Ehl; U Johnson; R Laven
Journal:  Pflugers Arch       Date:  1976-07-30       Impact factor: 3.657

2.  Cinnarizine in the treatment of peripheral vascular disease: mechanisms related to its clinical action.

Authors:  M B Emanuel; J A Will
Journal:  Proc R Soc Med       Date:  1977

Review 3.  Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis.

Authors:  Théophile Godfraind
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

4.  Comparative localization of inositol 1,4,5-trisphosphate and ryanodine receptors in intestinal smooth muscle: an analytical subfractionation study.

Authors:  M Wibo; T Godfraind
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

5.  Evidence for heterogeneity of endothelin receptor distribution in human coronary artery.

Authors:  T Godfraind
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

6.  Characterisation of marrubenol, a diterpene extracted from Marrubium vulgare, as an L-type calcium channel blocker.

Authors:  Sanae El-Bardai; Maurice Wibo; Marie-Christine Hamaide; Badiaa Lyoussi; Joelle Quetin-Leclercq; Nicole Morel
Journal:  Br J Pharmacol       Date:  2003-11-03       Impact factor: 8.739

7.  Actions of prostaglandin F2 alpha and noradrenaline on calcium exchange and contraction in rat mesenteric arteries and their sensitivity to calcium entry blockers.

Authors:  T Godfraind; R C Miller
Journal:  Br J Pharmacol       Date:  1982-01       Impact factor: 8.739

8.  Selective alpha 1- and alpha 2-adrenoceptor agonist-induced contractions and 45Ca fluxes in the rat isolated aorta.

Authors:  T Godfraind; R C Miller; J S Lima
Journal:  Br J Pharmacol       Date:  1982-12       Impact factor: 8.739

9.  Calcium exchange in vascular smooth muscle, action of noradrenaline and lanthanum.

Authors:  T Godfraind
Journal:  J Physiol       Date:  1976-08       Impact factor: 5.182

10.  Action of probucol in arteries from normal and hypercholesterolaemic rabbits.

Authors:  M Del Rio; T Chulia; E Ruiz; T Tejerina
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.